Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells.
Metformin is a major oral anti-diabetic drug and is known as an insulin sensitizer. However, the mechanism by which metformin acts is unclear. In this study, we found that AICAR, an AMPK activator, and metformin increased the expression of Rab4 mRNA and protein levels in skeletal muscle C2C12 cells. The promoter activity of Rab4 was increased by metformin in an AMPK-dependent manner. Metformin stimulated the phosphorylation of AS160, Akt substrate, and Rab GTPase activating protein (GAP), and also increased the phosphorylation of PKC-zeta, which is a critical molecule for glucose uptake. Knockdown of AMPK blocked the metformin-induced phosphorylation of AS160/PKC-zeta. In addition, a colorimetric absorbance assay showed that insulin-induced translocation of GLUT4 was suppressed in Rab4 knockdown cells. Moreover, Rab4 interacted with PKC-zeta but not with GLUT4. The C-terminal-deleted Rab4 mutant, Rab4ΔCT, showed diffuse sub-cellular localization, while wild-type Rab4 localized exclusively to the perinuclear membrane. Unlike Rab4ΔCT, wild-type Rab4 co-localized with PKC-zeta. Together, these results demonstrate that metformin induces Rab4 expression via AMPK-AS160-PKC-zeta and modulates insulin-mediated GLUT4 translocation.
Lee
Jung Ok
JO
Department of Anatomy, Korea University College of Medicine, Seoul, Korea.
Lee
Soo Kyung
SK
Jung
Jin Hee
JH
Kim
Ji Hae
JH
You
Ga Young
GY
Kim
Su Jin
SJ
Park
Sun Hwa
SH
Uhm
Kyung-Ok
KO
Kim
Hyeon Soo
HS
D000263:Adenylate Kinase / Q000378:metabolism*; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D005786:Gene Expression Regulation / Q000187:drug effects; D051275:Glucose Transporter Type 4 / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008687:Metformin / Q000494:pharmacology*; D051379:Mice; D032342:Muscle Cells / Q000187:drug effects* / Q000201:enzymology*; D018482:Muscle, Skeletal / Q000166:cytology*; D050505:Mutant Proteins / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D010768:Phosphoserine / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D011493:Protein Kinase C / Q000378:metabolism; D017434:Protein Structure, Tertiary; D021381:Protein Transport / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012265:Ribonucleotides / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D020695:rab4 GTP-Binding Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D051275:Glucose Transporter Type 4; D007328:Insulin; D050505:Mutant Proteins; D012333:RNA, Messenger; D012265:Ribonucleotides; D010768:Phosphoserine; D000620:Aminoimidazole Carboxamide; D008687:Metformin; C081975:protein kinase C eta; D011493:Protein Kinase C; D000263:Adenylate Kinase; D020695:rab4 GTP-Binding Proteins; C031143:AICA ribonucleotide